Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are leading causes of morbidity and mortality worldwide. Through shared risk factors and pathophysiological mechanisms, CHF and COPD frequently coexist. The concurrent disease has important therapeutic implications and independently predicts worsened mortality, impaired functional status, and health service use. However, assessment of the comorbidity varies widely according to the population studied, diagnostic criteria and measurement tools applied. Both syndromes have been studied extensively but largely separately, mostly in the domain of the pulmonologist for COPD and in the domain of the cardiologist for CHF.
Italian Survey on Prevalence and Disease Management of Chronic Heart Failure and Chronic Obstructive Pulmonary Disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design / Griffo, R.; Spanevello, A.; Temporelli, P. l.; Faggiano, P.; Carones, M.; Magni, G.; Ambrosino, N.; Tavazzi, L; Giannuzzi, P.; Balbi, B.; Caporotondi, A.; Fracchia, C.; Pedretti, R. f.; Spanevello, A.; Del Corso, L.; Scrabogna, P.; Passantino, A.; Carone, M.; Chieffo, C.; de Blasio, F.; Bertoli, D.; Bancalari, L.; Fattirolli, F.; Pistoiesi, M.; Carlon, R.; Idotta, G.; Vigorito, Carlo; Mormile, Mauro. - In: MONALDI ARCHIVES FOR CHEST DISEASE. - ISSN 1122-0643. - 82:1(2014), pp. 29-34.
Italian Survey on Prevalence and Disease Management of Chronic Heart Failure and Chronic Obstructive Pulmonary Disease comorbidity in ambulatory patients. SUSPIRIUM study rationale and design
VIGORITO, CARLO;MORMILE, MAURO
2014
Abstract
Chronic heart failure (CHF) and chronic obstructive pulmonary disease (COPD) are leading causes of morbidity and mortality worldwide. Through shared risk factors and pathophysiological mechanisms, CHF and COPD frequently coexist. The concurrent disease has important therapeutic implications and independently predicts worsened mortality, impaired functional status, and health service use. However, assessment of the comorbidity varies widely according to the population studied, diagnostic criteria and measurement tools applied. Both syndromes have been studied extensively but largely separately, mostly in the domain of the pulmonologist for COPD and in the domain of the cardiologist for CHF.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
